REVIEW: PENGARUH PEMBENTUKAN KOKRISTAL MENGGUNAKAN KOFORMER ASAM KARBOKSILAT DENGAN METODE SOLVENT EVAPORATION DAN SOLVENT DROP GRINDING TERHADAP BIOAVAILABILITAS ZAT AKTIF

Penulis

  • Rival Ferdiansyah Sekolah Tinggi Farmasi Indonesia http://orcid.org/0000-0003-0649-1130
  • Seno Aulia Ardiansyah Sekolah Tinggi Farmasi Indonesia
  • Revika Rachmaniar Sekolah Tinggi Farmasi Indonesia
  • Indriani Yuniar Sekolah Tinggi Farmasi Indonesia

DOI:

https://doi.org/10.52434/jfb.v12i1.987

Abstrak

Kelarutan merupakan faktor fisikokimia penting yang mempengaruhi bioavailabilitas dan efektivitas terapi obat. Sekitar 40% atau lebih dari kandidat obat yang tersedia memiliki kelarutan yang rendah dalam air sehingga kelarutan dari zat aktif perlu ditingkatkan agar bioavailabilitasnya ikut meningkat, salah satunya dengan cara teknik kokristalisasi. Dalam studi ini akan dikemukakan review terkait pengaruh pembentukan kokristal zat aktif yang memiliki kelarutan rendah dalam air menggunakan koformer golongan asam karboksilat dengan metode solvent evaporation dan solvent drop grinding terhadap peningkatan bioavailabilitas. Zat aktif yang berhasil dibuat kokristal dengan peningkatan bioavailabilitas menggunakan koformer golongan asam karboksilat dengan metode solvent evaporation yaitu apixaban, aceclofenac, klorbipram, telmisartan, paliperidon, dan metronidazol, sedangkan untuk metode solvent drop grinding diantaranya ketokonazol, meloksikam, dipfluzin, asam galat, gliclazid, dan itrakonazol. Berdasarkan kajian pustaka, dapat disimpulkan bahwa pembentukan kokristal menggunakan koformer golongan asam karboksilat dengan metode solvent evaporation dan solvent drop grinding berpotensi meningkatkan bioavailabilitas zat aktif. Peningkatan terjadi karena terbentuk ikatan hidrogen antara zat aktif dengan koformernya serta adanya fase kristal baru yang menandakan kokristal telah terbentuk dan mengindikasikan peningkatan kelarutan sehingga bioavailabilitasnya ikut meningkat. Kata kunci: Bioavailabilitas, kokristal, koformer golongan asam karboksilat, kokristal, solvent drop grinding, solvent evaporation.

Referensi

Gaucher G, Satturwar P, Jones MC, Furtos A, Leroux JC. Polymeric Micelles for Oral Drug Delivery. Eur J Pharm and Biopharm. 2010;76(2): 147-58.

Xu W, Ling P, Zhang T. Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water Soluble Drugs. J Drug Deliv. 2013: 1-15.

Husni AIDP. Artikel Tinjauan: Teknik Meningkatkan Kelarutan Obat. Farmaka. 2017;15(4): 49-57.

Zaini E, Halim A, Soewandhi SN, Setyawan D. Peningkatan Laju Pelarutan Trimetoprim Melalui Metode Kokristal Dengan Nikotinamid. Jurnal Farmasi Indonesia. 2011;5(4): 205-12.

Chen Y, Li L, Yao J, Ma Y, Chen JM, Lu TB. Improving the Solubility and Bioavailability of Apixaban via Apixaban-Oxalic Acid Cocrystal. Crystal Growth & Design. 2016;16: 2923-30.

Perlovich GL, Manin AN. Design of Pharmaceutical Cocrystal for Drug Solubility Improvement. Russian J General Chem. 2014;84(2): 407-14.

Lu J, Rohani S. Synthesis and preliminary characretization of sulfamethazine-theophylline co-crystal. J Pharm Sci [Internet]. 2010;99(9): 4042-47. Available from: https://doi.org/10.1002/jps.22142

Qiao N, Li M, Schlindwein W, Malek N, Davies A, Trappitt G. Pharmaceutical cocrystals: An Overview. Int J Pharm [Internet]. 2011;419(1-2): 1-11. Available from: https://doi.org/10.1016/j.ijpharm.2011.07.037

Tomaszewska I, Karki S, Shur J, Price R, Fotaki N. Pharmaceutical Characterization and Evaluation Of Cocrystals: Importance Of In Vitro Dissolution Conditions and Type Of Coformer. Int J Pharm. 2013;453(2): 380-88.

Siswanto A, Achmad F, Akhmad KN, Sudibyo M. Uji Bioavailabilitas Tablet Floating Aspirin. Jurnal Kefarmasian Indonesia. 2017;7(2): 112-19.

Shargel L., Wu-Pong S, Yu, ABC. Biofarmasetika dan Farmakokinetika Terapan, edisi 5. (diterjemahkan oleh Fasich dan Suprapti, B). Surabaya: Pusat Penerbitan dan Percetakan Universitas Airlangga. 2015. 384-386p, 453-460p, 460-465p.

Thakuria R, Delori A, Jones W, Lipert MP, Roy L, Hornedo NR. Pharmaceutical cocrystal and poorly soluble drugs. Int J Pharm. 2012;453(1): 380-88.

Triani F. Pengaruh Metode Pembentukan Kokristal Terhadap Laju Pelarutan Karbamazepin Menggunakan Asam Suksinat Sebagai Koformer [Skripsi]. Depok: Fakultas Matematika dan Ilmu Pengetahuan Alam Program Studi Ekstensi Farmasi Universitas Indonesia. 2012. 4-5.

Rizkianna. Pengaruh Metode Pembuatan Kokristal Terhadap Laju Pelarutan Karbamazepin Menggunakan Asam Tartrat Sebagai Koformer [Skripsi]. Depok: Fakultas Matematika dan Ilmu Pengetahuan Alam Program Studi Farmasi Universitas Indonesia. 2012. 5-6.

Kothur RR, Swetha AS, Bondili NP. An Outline of Crystal Engineering of Pharmaceutical Co-Crystal and Applications: A Review. Int J Pharm Research and Development. 2012;4(08): 84-92.

Alatas F, Azizsidiq FA, Sutarna TH, Ratih H, Soewandhi SN. Perbaikan Kelarutan Albendazol Melalui Pembentukan Kristal Multikomponen dengan Asam Malat. Galenica J Pharm. 2020;6(1): 114-23.

Permatasari D, Ramadhani S, Sopyan I, Muchtaridi. Ko-Kristal: Teknik Pembuatan Kokristal. Farmaka. 2016;14(4): 98-115.

Verma S, Arum N., Basu SP. Improvement of solubility and bioavailability of aceclofenac using cocrystallization. Drug Intervention Today. 2019;11(1): 59-63.

Zhou J, Li L, Zhang H, Xu J, Huang D, Gong N, Han W, Yang W, Zhou Z. Crystal Structures, Dissolution and Pharmacokinetic Study on a Novel Phosphodiesterase-4 Inhibitor Chlorbipram Cocrystals. International Journal of Pharmaceutics. 2019;576: 1-39.

Haneef J, Arora P, Chadha R. Implication of Coformer Structural Diversity on Cocrystallization Outcomes of Telmisartan with Improved Biopharmaceutical Performance. American Association Pharm Sci. 2019;21(10): 1-11.

Thimmasetty J, Ghosh T, Nayak NS, Raheem A. Oral Bioavailability enchancement of Paliperidone by the use of Cocrystalization and Precipitation Inhibition. J Pharm Innov. 2020: 1-10.

Zheng K, Li A, Wu W, Qian S, Liu B. Preparation, characterization, in vitro and in vivo evaluation of metronidazole-gallic acid cocrystal: A combined experimental and theoretical investigation. J Molecular Structure. 2019;1197: 727-35.

Chadha R, Bhandari S, Haneef J, Khullar S, Mandal S. Cocrystals of telmisartan: characterization, structure elucidation, in vivo and toxicity studies. Royal Society Chem. 2014;16: 8375–89.

Kotak U, Prajapati V, Solanki H, Jani G, Jha P. Co-Crystallization Technique Its Rationable and Recent Progress. World J Pharm and Pharmaceutical Sci. 2015;4(04): 1484-08.

Martin F, Pop M, Kacso I, Grosu IG, Miciaus M, Vodnar D, Lung I, Filip GA, Olteanu ED, Moldovan R, Nagy A, Filip X, Baldea I. Ketoconazole - p-aminobenzoic acid cocrystal: revival of an old drug by crystal engineering. Molecular Pharm. 2020: 1-47.

Cheney ML, Weyna DR, Shan N, Hanna M, Wojtas L, Zaworotko MJ. Coformer Selection in Pharmaceutical Cocrystal Development: a Case Study of a Meloxicam Aspirin Cocrystal That Exhibits Enhanced Solubility and Pharmacokinetics. J Pharm Sci. 2011;100(6): 2172-81.

Lin Y, Yang H, Yang C, Wang J. Preparation, Characterization, and Evaluation of Dipfluzine–Benzoic Acid Co-crystals with Improved Physicochemical Properties. Pharm Res. 2013: 1-13.

Weyna DR, Cheney ML, Hana M, Zaworotko MJ, Sava V, Song S, Ramos JRS. Improving Solubility and Pharmacokinetics of Meloxicam via Multiple - Component Crystal Formation. Mol Pharmaceutics. 2012;9: 2094-2102.

Xue N, Jia Y, Li C, He B, Yang C, Wang J. Characterizations and Assays of α-Glucosidase Inhibition Activity on Gallic Acid Cocrystals: Can the Cocrystals be Defined as a New Chemical Entity During Binding with the α-Glucosidase?. Molecules MDPI. 2020;25(1163): 1-13.

Chadha R, Rani D, Goyal P. Novel Cocrystals Of Glicazide: Characterization and Evaluation. Royal Society Chem. 2016: 1-19.

De Smet L, Saerens L, De Beer T, Carleer R, Adriaensens, Bocxlaer JV, Vervaet C, Remon JP. Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs. Eur J Pharm and Biopharm. 2014: 1-7.

Erlianti R, Darusman F, Effendi DH. Praperlakuan Bahan Baku Glimepirid Melalui Metode Kokristalisasi Untuk Meningkatkan Kalarutan dan Laju Disolusi. In: Prosiding Penelitian SPeSIA Unisba. 2015. p. 671-79.

Sopyan I, Nurhayati D, Budiman A, Kurniawanyah IS. Peningkatan Laju Pelarutan dan Simvastatin melalui Penedekatan Nonkovalen Derivatif Menggunakan Metode Solvent Drop Grinding. In: Prosiding APC (Annual Pharmacy Conference). 2019. p. 25-33.

Unduhan

Diterbitkan

2021-02-24

Terbitan

Vol 12 No 1 (2021): Jurnal Ilmiah Farmako Bahari

Bagian

Research Article

Lisensi

or all articles published in Jurnal Ilmiah Farmako Bahari, the copyright is retained by the journal. Articles are published under the terms of Creative Commons Attribution-ShareAlike 4.0 International License (CC-BY-SA 4.0) .

For Authors:

  • Any article on the copyright is retained by the author(s).
  • The author grants the journal, right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles of work (eg, post-institutional repository) or publish it in a book, with acknowledgment of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process, as can lead to productive exchanges, as well as earlier and greater citation of published work.
  • The article and any associated published material is distributed under the Creative Commons Attribution-ShareAlike 4.0 International License